NEW YORK (GenomeWeb) — GNS Healthcare has completed a $10 million Series C financing round, led by new investors including Celgene, Alexandria Real Estate Equities, and Gi Global Health Fund.

The new investors joined prior investors in the round, including Cambia Health Solutions, Heritage Provider Network, and Mitsui USA.

The firm said it would use the funds to accelerate its machine learning-based software for precision medicine, including new cloud-based data solutions.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.